NCT04926597 Effect of Continued Nutritional Support at Hospital Discharge on Mortality, Frailty, Functional Outcomes and Recovery
| NCT ID | NCT04926597 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Philipp Schuetz |
| Condition | Malnutrition |
| Study Type | INTERVENTIONAL |
| Enrollment | 1,200 participants |
| Start Date | 2021-08-05 |
| Primary Completion | 2026-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 1,200 participants in total. It began in 2021-08-05 with a primary completion date of 2026-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study is to compare the sustained post-discharge nutritional support to reach individual energy and protein goals to usual care home nutrition in medical patients at nutritional risk.
Eligibility Criteria
Inclusion Criteria: * Informed Consent as documented by signature * Adult (age ≥18 years), medical patients * Nutritional risk screening using the Nutritional Risk Screening (NRS): total score ≥3 points consisting of ≥1 points for impairment of the nutritional status \[weight loss \>5% in 3 month or food intake of 50-75% in the last week before hospital admission\] plus ≥1 for the severity of the disease (i.e., cancer, chronic kidney disease, chronic heart failure, COPD) and other chronic diseases according to the definition of the "National Center for Chronic Disease Prevention and Health Promotion": Chronic diseases are defined broadly as conditions that last 1 year or more and require ongoing medical attention or limit activities of daily living or both . Exclusion Criteria: * after surgery * unable to ingest oral nutrition * need for long-term nutrition, * terminal condition * acute pancreatitis or acute liver failure * patients discharged to a nursing home * patients unlikely to comply with nutritional support treatment (e.g., dementia) * COVID-Hospitalisation requiring intensive care
Contact & Investigator
Philipp Schuetz, Prof. Dr. med.
PRINCIPAL INVESTIGATOR
Kantonsspital Aarau, University Department of Internal Medicine
Frequently Asked Questions
Who can join the NCT04926597 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Malnutrition. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT04926597 currently recruiting?
Yes, NCT04926597 is actively recruiting participants. Contact the research team at Philipp.Schuetz@unibas.ch for enrollment information.
Where is the NCT04926597 trial being conducted?
This trial is being conducted at Barcelona, Spain, Getafe, Spain, León, Spain, Madrid, Spain and 11 additional locations.
Who is sponsoring the NCT04926597 clinical trial?
NCT04926597 is sponsored by Philipp Schuetz. The principal investigator is Philipp Schuetz, Prof. Dr. med. at Kantonsspital Aarau, University Department of Internal Medicine. The trial plans to enroll 1,200 participants.